Behbahani Ali bought SpyGlass Pharma ($SGP) shares once on the open market in the last year, totaling 15 million dollars with the most recent purchase on February 9, 2026. This ranks 84th out of 4,983 insiders, far above the average of 1.5 million dollars per buyer.
He sold NeueHealth ($NEUE) shares four times for 26 thousand dollars, most recently on October 2, 2025, ranking 10,893rd out of 11,678 insiders with average sales of 8.6 million dollars. He also sold Adaptimmune Therapeutics ($ADAPY) shares twice for 229 thousand dollars, most recently on August 18, 2025, ranking 8,131st.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 20, 2026 | Black Diamond Therapeutics, Inc. | $BDTX | Behbahani Ali | Not found | A | Common Stock | 6919 | $2.15 | 4,542,325.0000 | 57,480,512 | 0.15% | 0.01% |
| March 10, 2026 | Korro Bio, Inc. | $KRRO | Behbahani Ali | Not found | A | Pre-Funded Warrants | 242945 | $11.11 | 242,945.0000 | 9,417,295 | 9999.99% | 2.58% |
| March 10, 2026 | Korro Bio, Inc. | $KRRO | Behbahani Ali | Not found | A | Common Stock | 207100 | $11.11 | 1,297,893.0000 | 9,417,295 | 18.99% | 2.20% |
| April 17, 2025 | Trevi Therapeutics, Inc. | $TRVI | Behbahani Ali | Not found | X | Common Stock | 1851852 | $1.37 | 13,222,228.0000 | 101,971,873 | 16.29% | 1.82% |
| April 17, 2025 | Trevi Therapeutics, Inc. | $TRVI | Behbahani Ali | Not found | X | 3.5-Year Common Stock Warrant | 1851852 | $0.00 | 0.0000 | 101,971,873 | 100.00% | 1.82% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | Behbahani Ali | Not found | C | Series C-2 Preferred Stock | 1370168 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | Behbahani Ali | Not found | C | Common Stock | 1619240 | $0.00 | 2,976,503.0000 | 0 | 119.30% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | Behbahani Ali | Not found | C | Common Stock | 1370168 | $0.00 | 4,346,671.0000 | 0 | 46.03% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | Behbahani Ali | Not found | C | Series C-1 Preferred Stock | 1370168 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | Behbahani Ali | Not found | C | Series D Preferred Stock | 737962 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | Behbahani Ali | Not found | C | Common Stock | 1370168 | $0.00 | 5,716,839.0000 | 0 | 31.52% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | Behbahani Ali | Not found | C | Common Stock | 737962 | $0.00 | 6,454,801.0000 | 0 | 12.91% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | Behbahani Ali | Not found | P | Common Stock | 937500 | $16.00 | 7,392,301.0000 | 0 | 14.52% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | Behbahani Ali | Not found | C | Series B Preferred Stock | 402273 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | Behbahani Ali | Not found | C | Common Stock | 954990 | $0.00 | 6,990,028.0000 | 0 | 15.82% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | Behbahani Ali | Not found | C | Series A Preferred Stock | 954990 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | Behbahani Ali | Not found | C | Common Stock | 402273 | $0.00 | 7,392,301.0000 | 0 | 5.75% | 0.00% |
| Feb. 9, 2026 | SpyGlass Pharma, Inc. | $SGP | Behbahani Ali | Not found | C | Series B Preferred Stock | 1619240 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 5, 2026 | SpyGlass Pharma, Inc. | $SGP | Behbahani Ali | Not found | A | Stock Option (right to buy) | 27400 | $0.00 | 27,400.0000 | 0 | 9999.99% | 0.00% |
| Dec. 12, 2025 | Black Diamond Therapeutics, Inc. | $BDTX | Behbahani Ali | Not found | A | Common Stock | 5208 | $2.76 | 4,535,406.0000 | 57,480,512 | 0.11% | 0.01% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | X | Warrant (Right to Buy) | 1656789 | $0.00 | 0.0000 | 9,024,240 | 100.00% | 18.36% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | M | Common Stock | 186128 | $0.01 | 674,830.0000 | 9,024,240 | 38.09% | 2.06% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | F | Common Stock | 276 | $6.75 | 674,554.0000 | 9,024,240 | 0.04% | 0.00% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | D | Common Stock | 674554 | $0.00 | 0.0000 | 9,024,240 | 100.00% | 7.47% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | X | Common Stock | 1656789 | $0.01 | 1,656,789.0000 | 9,024,240 | 9999.99% | 18.36% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | S | Common Stock | 2455 | $6.75 | 1,654,334.0000 | 9,024,240 | 0.15% | 0.03% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | X | Common Stock | 607536 | $0.01 | 2,261,870.0000 | 9,024,240 | 36.72% | 6.73% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | S | Common Stock | 900 | $6.75 | 2,260,970.0000 | 9,024,240 | 0.04% | 0.01% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | M | Common Stock | 124085 | $0.01 | 2,385,055.0000 | 9,024,240 | 5.49% | 1.38% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | F | Common Stock | 182 | $6.75 | 2,384,873.0000 | 9,024,240 | 0.01% | 0.00% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | D | Common Stock | 2384873 | $0.00 | 0.0000 | 9,024,240 | 100.00% | 26.43% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | X | Warrant (Right to Buy) | 189195 | $0.00 | 0.0000 | 9,024,240 | 100.00% | 2.10% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | A | Warrant (Right to Buy) | 372255 | $0.00 | 372,255.0000 | 9,024,240 | 9999.99% | 4.13% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | M | Warrant (Right to Buy) | 372255 | $0.00 | 0.0000 | 9,024,240 | 100.00% | 4.13% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | X | Warrant (Right to Buy) | 189195 | $0.00 | 0.0000 | 9,024,240 | 100.00% | 2.10% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | A | Warrant (Right to Buy) | 186128 | $0.00 | 186,128.0000 | 9,024,240 | 9999.99% | 2.06% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | M | Warrant (Right to Buy) | 186128 | $0.00 | 0.0000 | 9,024,240 | 100.00% | 2.06% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | D | Series A Convertible Perpetual Preferred Stock | 75000 | $0.00 | 0.0000 | 9,024,240 | 100.00% | 0.83% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | D | Series B Convertible Perpetual Preferred Stock | 37700 | $0.00 | 0.0000 | 9,024,240 | 100.00% | 0.42% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | X | Warrant (Right to Buy) | 607536 | $0.00 | 0.0000 | 9,024,240 | 100.00% | 6.73% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | A | Warrant (Right to Buy) | 124085 | $0.00 | 124,085.0000 | 9,024,240 | 9999.99% | 1.38% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | M | Warrant (Right to Buy) | 124085 | $0.00 | 0.0000 | 9,024,240 | 100.00% | 1.38% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | D | Series A Convertible Perpetual Preferred Stock | 125000 | $0.00 | 0.0000 | 9,024,240 | 100.00% | 1.39% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | D | Series B Convertible Perpetual Preferred Stock | 100000 | $0.00 | 0.0000 | 9,024,240 | 100.00% | 1.11% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | X | Common Stock | 189195 | $0.01 | 788,259.0000 | 9,024,240 | 31.58% | 2.10% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | S | Common Stock | 280 | $6.75 | 787,979.0000 | 9,024,240 | 0.04% | 0.00% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | M | Common Stock | 372255 | $0.01 | 1,160,234.0000 | 9,024,240 | 47.24% | 4.13% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | F | Common Stock | 551 | $6.75 | 1,159,683.0000 | 9,024,240 | 0.05% | 0.01% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | D | Common Stock | 1159683 | $0.00 | 0.0000 | 9,024,240 | 100.00% | 12.85% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | X | Common Stock | 189195 | $0.01 | 488,982.0000 | 9,024,240 | 63.11% | 2.10% |
| Oct. 2, 2025 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | S | Common Stock | 280 | $6.75 | 488,702.0000 | 9,024,240 | 0.06% | 0.00% |
| Sept. 19, 2025 | Black Diamond Therapeutics, Inc. | $BDTX | Behbahani Ali | Not found | A | Common Stock | 4291 | $3.35 | 4,530,198.0000 | 55,028,371 | 0.09% | 0.01% |
| Aug. 15, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Behbahani Ali | Not found | S | Ordinary Shares with a nominal value of 0.001 GBP per share | 4828206 | $0.01 | 14,671,794.0000 | 1,584,522,868 | 24.76% | 0.30% |
| Aug. 18, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Behbahani Ali | Not found | S | Ordinary Shares with a nominal value of 0.001 GBP per share | 14671794 | $0.01 | 0.0000 | 1,584,522,868 | 100.00% | 0.93% |
| Aug. 12, 2025 | Arcellx, Inc. | $ACLX | Behbahani Ali | Not found | J | Common Stock | 1586 | $0.00 | 4,631.0000 | 54,944,012 | 52.09% | 0.00% |
| Aug. 12, 2025 | Arcellx, Inc. | $ACLX | Behbahani Ali | Not found | J | Common Stock | 2621 | $0.00 | 4,631.0000 | 54,944,012 | 130.40% | 0.00% |
| June 20, 2025 | Black Diamond Therapeutics, Inc. | $BDTX | Behbahani Ali | Not found | A | Common Stock | 6170 | $2.33 | 4,525,907.0000 | 55,028,371 | 0.14% | 0.01% |
| June 13, 2025 | Monte Rosa Therapeutics, Inc. | $GLUE | Behbahani Ali | Not found | A | Stock Option (Right to Buy) | 30700 | $0.00 | 30,700.0000 | 73,910,026 | 9999.99% | 0.04% |
| June 11, 2025 | Korro Bio, Inc. | $KRRO | Behbahani Ali | Not found | A | Stock Option (Right to Buy) | 6010 | $0.00 | 6,010.0000 | 9,388,902 | 9999.99% | 0.06% |
| June 12, 2025 | Black Diamond Therapeutics, Inc. | $BDTX | Behbahani Ali | Not found | A | Stock Option (Right to Buy) | 30550 | $0.00 | 30,550.0000 | 55,028,371 | 9999.99% | 0.06% |
| June 5, 2025 | Nkarta, Inc. | $NKTX | Behbahani Ali | Not found | A | Stock Option (right to buy) | 46000 | $0.00 | 46,000.0000 | 67,865,323 | 9999.99% | 0.07% |
| June 5, 2025 | CRISPR Therapeutics AG | $CRSP | Behbahani Ali | Not found | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 85,774,474 | 9999.99% | 0.02% |
| May 29, 2025 | Arcellx, Inc. | $ACLX | Behbahani Ali | Not found | A | Stock Option (right to buy) | 9174 | $0.00 | 9,174.0000 | 54,944,012 | 9999.99% | 0.02% |
| March 21, 2025 | Black Diamond Therapeutics, Inc. | $BDTX | Behbahani Ali | Not found | A | Common Stock | 7646 | $1.88 | 4,519,737.0000 | 55,028,371 | 0.17% | 0.01% |
| Dec. 13, 2024 | Black Diamond Therapeutics, Inc. | $BDTX | Behbahani Ali | Not found | A | Common Stock | 5750 | $2.50 | 4,512,091.0000 | 56,507,956 | 0.13% | 0.01% |
| Oct. 1, 2024 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | P | Warrant (Right to Buy) | 61865 | $0.00 | 927,970.0000 | 0 | 7.14% | 0.00% |
| Oct. 1, 2024 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | P | Warrant (Right to Buy) | 61865 | $0.00 | 927,970.0000 | 0 | 7.14% | 0.00% |
| Oct. 1, 2024 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | P | Warrant (Right to Buy) | 185595 | $0.00 | 927,970.0000 | 0 | 25.00% | 0.00% |
| Sept. 20, 2024 | Black Diamond Therapeutics, Inc. | $BDTX | Behbahani Ali | Not found | A | Common Stock | 3007 | $4.78 | 4,506,341.0000 | 43,954,649 | 0.07% | 0.01% |
| Sept. 16, 2024 | MBX Biosciences, Inc. | $MBX | Behbahani Ali | Not found | C | Common Stock | 1023103 | $0.00 | 1,023,103.0000 | 0 | 9999.99% | 0.00% |
| Sept. 16, 2024 | MBX Biosciences, Inc. | $MBX | Behbahani Ali | Not found | C | Common Stock | 2091383 | $0.00 | 3,114,486.0000 | 0 | 204.42% | 0.00% |
| Sept. 16, 2024 | MBX Biosciences, Inc. | $MBX | Behbahani Ali | Not found | C | Series B Convertible Preferred Stock | 25142840 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 16, 2024 | MBX Biosciences, Inc. | $MBX | Behbahani Ali | Not found | C | Series A Convertible Preferred Stock | 12299854 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 16, 2024 | MBX Biosciences, Inc. | $MBX | Behbahani Ali | Not found | P | Common Stock | 500000 | $16.00 | 3,614,486.0000 | 0 | 16.05% | 0.00% |
| July 1, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Behbahani Ali | Not found | A | Option to purchase Ordinary Shares | 1144686 | $0.00 | 1,144,686.0000 | 1,559,183,774 | 9999.99% | 0.07% |
| June 21, 2024 | Black Diamond Therapeutics, Inc. | $BDTX | Behbahani Ali | Not found | A | Common Stock | 2887 | $4.98 | 4,503,334.0000 | 43,954,649 | 0.06% | 0.01% |
| June 13, 2024 | Nkarta, Inc. | $NKTX | Behbahani Ali | Not found | A | Stock Option (right to buy) | 22500 | $0.00 | 22,500.0000 | 49,014,300 | 9999.99% | 0.05% |
| June 12, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Behbahani Ali | Not found | A | Stock Option (Right to Buy) | 22100 | $0.00 | 22,100.0000 | 51,396,961 | 9999.99% | 0.04% |
| June 11, 2024 | Korro Bio, Inc. | $KRRO | Behbahani Ali | Not found | A | Stock Option (Right to Buy) | 5190 | $0.00 | 5,190.0000 | 0 | 9999.99% | 0.00% |
| June 4, 2024 | CVRx, Inc. | $CVRX | Behbahani Ali | Not found | A | Stock Option (right to buy) | 27250 | $0.00 | 27,250.0000 | 21,232,009 | 9999.99% | 0.13% |
| May 28, 2024 | Arcellx, Inc. | $ACLX | Behbahani Ali | Not found | A | Stock Option (right to buy) | 8011 | $0.00 | 8,011.0000 | 0 | 9999.99% | 0.00% |
| June 4, 2024 | CVRx, Inc. | $CVRX | Behbahani Ali | Not found | A | Stock Option (right to buy) | 20961 | $0.00 | 20,961.0000 | 21,232,009 | 9999.99% | 0.10% |
| June 6, 2024 | Black Diamond Therapeutics, Inc. | $BDTX | Behbahani Ali | Not found | A | Stock Option (Right to Buy) | 30550 | $0.00 | 30,550.0000 | 43,954,649 | 9999.99% | 0.07% |
| May 30, 2024 | CRISPR Therapeutics AG | $CRSP | Behbahani Ali | Not found | A | Stock Option (Right to buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |
| April 22, 2024 | Korro Bio, Inc. | $KRRO | Behbahani Ali | Not found | A | Common Stock | 17857 | $56.00 | 1,090,793.0000 | 0 | 1.66% | 0.00% |
| April 8, 2024 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | P | Warrant (Right to Buy) | 123729 | $0.00 | 618,645.0000 | 0 | 25.00% | 0.00% |
| April 8, 2024 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | P | Warrant (Right to Buy) | 371187 | $0.00 | 618,645.0000 | 0 | 150.00% | 0.00% |
| April 8, 2024 | NeueHealth, Inc. | $NEUE | Behbahani Ali | Not found | P | Warrant (Right to Buy) | 123729 | $0.00 | 618,645.0000 | 0 | 25.00% | 0.00% |
| March 15, 2024 | Black Diamond Therapeutics, Inc. | $BDTX | Behbahani Ali | Not found | A | Common Stock | 3166 | $4.54 | 4,500,447.0000 | 43,954,649 | 0.07% | 0.01% |
| Jan. 15, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Behbahani Ali | Director | A | Option to purchase Ordinary Shares | 40950 | $0.00 | 40,950.0000 | 1,206,440,978 | 9999.99% | 0.00% |
| Dec. 19, 2023 | NeueHealth, Inc. | $NEUE | Behbahani Ali | TenPercentOwner | P | Warrant (Right to Buy) | 175525 | $0.00 | 1,656,789.0000 | 0 | 11.85% | 0.00% |
| Dec. 14, 2023 | CVRx, Inc. | $CVRX | Behbahani Ali | Director | M | Common Stock | 316 | $0.24 | 316.0000 | 20,801,350 | 9999.99% | 0.00% |
| Dec. 14, 2023 | CVRx, Inc. | $CVRX | Behbahani Ali | Director | M | Stock Option (right to buy) | 316 | $0.00 | 0.0000 | 20,801,350 | 100.00% | 0.00% |
| Nov. 3, 2023 | Korro Bio, Inc. | $KRRO | Behbahani Ali | Director | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 3, 2023 | Korro Bio, Inc. | $KRRO | Behbahani Ali | Director | A | Common Stock | 1072936 | $0.00 | 1,072,936.0000 | 0 | 9999.99% | 0.00% |
| Oct. 31, 2023 | NeueHealth, Inc. | $NEUE | Behbahani Ali | TenPercentOwner | P | Warrant (Right to Buy) | 100606 | $0.00 | 1,481,264.0000 | 0 | 7.29% | 0.00% |
| Sept. 15, 2023 | NeueHealth, Inc. | $NEUE | Behbahani Ali | TenPercentOwner | P | Warrant (Right to Buy) | 552263 | $0.00 | 1,380,658.0000 | 0 | 66.67% | 0.00% |
| Aug. 11, 2023 | NeueHealth, Inc. | $NEUE | Behbahani Ali | TenPercentOwner | P | Warrant (Right to Buy) | 828395 | $0.00 | 828,395.0000 | 0 | 9999.99% | 0.00% |
| July 17, 2023 | Savara Inc | $SVRA | Behbahani Ali | TenPercentOwner | P | Common Stock | 333333 | $3.00 | 24,471,264.0000 | 0 | 1.38% | 0.00% |
| June 14, 2023 | Arcellx, Inc. | $ACLX | Behbahani Ali | Director | A | Stock Option (right to buy) | 11459 | $0.00 | 11,459.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | CRISPR Therapeutics AG | $CRSP | Behbahani Ali | Director | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2023 | CVRx, Inc. | $CVRX | Behbahani Ali | Director | A | Stock Option (right to buy) | 12012 | $0.00 | 12,012.0000 | 20,693,224 | 50.00% | 0.06% |
| June 1, 2023 | Arcellx, Inc. | $ACLX | Behbahani Ali | Director | J | Common Stock | 113 | $0.00 | 424.0000 | 0 | 36.33% | 0.00% |
| June 1, 2023 | Arcellx, Inc. | $ACLX | Behbahani Ali | Director | J | Common Stock | 28 | $0.00 | 424.0000 | 0 | 7.07% | 0.00% |